Chip designer Arm posted a 17 percent rise in underlying profit of 24.9 million pounds on Tuesday, and said revenue in the final quarter will meet or exceed expectations.

Even though the government chose Glaxo's Cervarix for its cervical cancer vaccine programme, many British doctors pick Merck's Gardasil for their own daughters, a well-known physician said on Friday.

U.S. researchers have found a way to switch on a cell-killing protein in the body, a finding that could lead to new ways to treat diseases like cancer in which cells grow out of control.

People who eat quickly until full are three times more likely to be overweight, a problem exacerbated by the availability of fast food and the decline of orderly dining habits, Japanese researchers said on Wednesday.

Young men who use anabolic steroids are twice as likely to engage in violence than those who do not use the muscle-building drugs, U.S. researchers said on Wednesday.

A long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks, researchers said on Monday, but this risk goes away a year after people stop taking it.

A protein in the inner ear helps people differentiate between sounds and understand speech, French researchers reported on Wednesday in a finding that could help treat the hard of hearing.

ImClone Systems has agreed to be acquired by Eli Lilly for about $6.1 billion (3.5 billion pounds) after rebuffing a sweetened takeover offer from Bristol-Myers Squibb, sources familiar with the situation said on Monday.

EDF confirmed on Monday that a board meeting will take place this week but declined to comment on the agenda.

French drugmaker Sanofi-Aventis on Wednesday named GlaxoSmithKline executive Chris Viehbacher as its new CEO, ousting former research head Gerard Le Fur after less than two years in the job.

Southern Cross Healthcare said Thursday Chief Executive Bill Colvin is to leave the company, as it announced another tranche of property sales.

Men are much less likely than women to live into their 90s, but those who do have a much lower chance of having Alzheimer's disease or another form of dementia, U.S. researchers said on Wednesday.

GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs.

Switzerland based pharmaceutical company Roche said on Monday that it had offered to buy the outstanding shares in its US partner Genentech for $43.7 billion (£22 billion).

AstraZeneca shares jumped more than 6 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder.

A laser treatment that wipes out drug-resistant bacterial infections may one day help doctors tackle the growing problem of superbugs, British researchers said on Tuesday.

A lower IQ increases a person's risk of developing a common form of dementia, a study found on Wednesday.

Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.

A cancer vaccine more than doubled the survival time of people with the most common and deadly type of brain tumor, U.S. researchers said on Monday.